Graded Prognostic Assessment (GPA) score for brain metastases treated with stereotactic radiosurgery

被引：0
|
作者：
Kumar, V. [1 ]
Mehmood, Q. [1 ]
Hindley, A. [1 ]
Singh, N. [2 ]
Ray, A. [2 ]
Davis, C. [2 ]
Law, J. [2 ]
Abbott, C. [1 ]
Benn-Mackay, C. [1 ]
Mathur, S. [3 ]
机构：
[1] Royal Preston Hosp, Oncol Dept, Rosemere Canc Ctr, Preston, Lancs, England
[2] Royal Preston Hosp, Dept Neurosurg, Preston, Lancs, England
[3] Royal Preston Hosp, Dept Neuroimaging, Preston, Lancs, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1386
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] GPA in brain metastases treated with Stereotactic Radiosurgery
    Rodriguez Medizabal, M. A.
    Rico Oses, M.
    Flamarique Andueza, S.
    Campo Vargas, M.
    Martin Martinez, A.
    Rosas, L. O.
    Martinez Lopez, E.
    Barrado, M.
    Pellejero, S.
    Maneru, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S478 - S479
  • [2] Correlation between graded prognostic assessment (GPA) and survival in primary lung cancer patients with brain metastases treated with stereotactic radiosurgery
    Lee, H.
    Appel, W.
    Bezecny, P.
    Hindley, A.
    Skailes, G.
    Sivaramalingam, M.
    Lau, S.
    Varadarajan, K.
    Benn, C.
    Abbott, C.
    LUNG CANCER, 2015, 87 : S54 - S54
  • [3] Radiotherapy of brain metastases according to the GPA score (Graded Prognostic Assessment)
    Antoni, D.
    Noel, G.
    CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 424 - 427
  • [4] Is the Graded Prognostic Assessment (GPA) Reliable for Patients Previously Treated for Brain Metastases?
    Tundisi, C.
    Santos, T. R.
    Ramos, H.
    Pellizzon, A. C.
    Maia, M. C.
    Silva, M. G.
    Fogaroli, R. C.
    Chen, M. J.
    Sanematsu Junior, P. I.
    Castro, D. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S298 - S298
  • [5] Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery
    van Ruitenbeek, Niels J.
    Ho, Vincent K. Y.
    Westgeest, Hans M.
    Beerepoot, Laurens V.
    Hanssens, Patrick E. J.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (03) : 527 - 536
  • [6] Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery
    Niels J. van Ruitenbeek
    Vincent K. Y. Ho
    Hans M. Westgeest
    Laurens V. Beerepoot
    Patrick E. J. Hanssens
    Journal of Neuro-Oncology, 2021, 153 : 527 - 536
  • [7] Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery
    Bian, Shelly X.
    Routman, David
    Liu, Jonathan
    Yang, Dongyun
    Groshen, Susan
    Zada, Gabriel
    Trakul, Nicholas
    Wong, Michael K.
    Yu, Cheng
    Chang, Eric L.
    JOURNAL OF NEUROSURGERY, 2016, 125 : 31 - 39
  • [8] Validating the SIR: a better prognostic score index for patients with brain metastases treated with stereotactic radiosurgery
    Weltman, Eduardo
    Brandt, Reynaldo Andre
    Hanriot, Rodrigo de Morais
    Luz, Fabio Prado
    Chen, Michael Jenwei
    Cruz, Jose Carlos
    Wajsbrot, Dalia Ballas
    Nadalin, Wladimir
    EINSTEIN-SAO PAULO, 2007, 5 (01): : 16 - 23
  • [9] Physician Assessment Versus the Graded Prognostic Assessment (GPA) for Brain Metastases
    Aggarwal, S.
    Prionas, N. D.
    Carter, J. N.
    Pradhan, P.
    Bui, J. L.
    Fujimoto, D. K.
    von Eyben, R.
    Koong, A. C.
    Chang, D. T.
    Ho, C. K.
    Soltys, S. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E126 - E126
  • [10] Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery
    Donofrio, Carmine Antonio
    Cavalli, Andrea
    Gemma, Marco
    Riccio, Lucia
    Donofrio, Alessandra
    Panni, Pietro
    da Passano, Camillo Ferrari
    Del Vecchio, Antonella
    Bolognesi, Angelo
    Soffietti, Riccardo
    Mortini, Pietro
    CLINICAL & EXPERIMENTAL METASTASIS, 2020, 37 (04) : 499 - 508
12345